Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX7ROZ
|
||||
Drug Name |
(R)-N-(1-cyanocyclopropyl)-3-(methylsulfinyl)-2-((S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethylamino)propanamide
|
||||
Synonyms |
CHEMBL250119
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C16H17F4N3O2S
|
||||
Canonical SMILES |
C[S+]([O-])C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC2(CC2)C#N
|
||||
InChI |
InChI=1S/C16H17F4N3O2S/c1-26(25)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24)/t12-,13-,26?/m0/s1
|
||||
InChIKey |
RTEXRRVBLWMVBG-GXXHEZNASA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
WikiPathways | RANKL/RANK Signaling Pathway | ||||
Osteoclast Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.